Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cancer of unknown primary (CUP), Secondary cancers
Closed
Phase 2
This trial is looking at pembrolizumab for people who have cancer of unknown primary (CUP).
Cancer of unknown primary means that cancer spread has been found in your body (secondary cancer). But your doctors can't find where the cancer started (the primary cancer).
Recruitment start: 22 February 2019
Recruitment end: 31 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Harpreet Wasan
Imperial College London
Merck, Sharp and Dohme
Last reviewed: 30 Dec 2022
CRUK internal database number: 15520
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
